Literature DB >> 32182131

Impact of Coronavirus Disease 2019 (COVID-19) Outbreak on ST-Segment-Elevation Myocardial Infarction Care in Hong Kong, China.

Chor-Cheung Frankie Tam1, Kent-Shek Cheung2, Simon Lam1, Anthony Wong1, Arthur Yung1, Michael Sze1, Yui-Ming Lam1, Carmen Chan1, Tat-Chi Tsang2, Matthew Tsui2, Hung-Fat Tse1, Chung-Wah Siu1.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32182131      PMCID: PMC7147280          DOI: 10.1161/CIRCOUTCOMES.120.006631

Source DB:  PubMed          Journal:  Circ Cardiovasc Qual Outcomes        ISSN: 1941-7713


× No keyword cloud information.
Acute ST-segment–elevation myocardial infarction (STEMI) is a disease of high mortality and morbidity, and primary percutaneous coronary intervention (PPCI) is the typical recommended therapy.[1,2] Systems of care have been established to expedite PPCI workflow to minimize ischemic time from symptom onset to definitive treatment in the catheterization laboratory. Little is known about the impact of public health emergencies like a community outbreak of infectious disease on STEMI systems of care. Since December 2019, the emergence of Coronavirus disease 2019 (COVID-19) in Wuhan, China, has evolved into a regional epidemic, including in Hong Kong, a city in Southern China. We describe the impact of the COVID-19 outbreak on STEMI care in Hong Kong through a handful of recent cases of patients with STEMI who underwent PPCI at a single center. We included patients with STEMI admitted via the Accident and Emergency Department and in whom PPCI was performed. We focus on the time period since January 25, 2020, when hospitals in the city started to institute emergency infection protocols to contain COVID-19. This required hospitals to suspend all nonessential visits and adjust clinical in-patient and out-patient services. Indications for PPCI were according to the international guidelines.[1,2] Study exclusion criteria included inpatient STEMI (n=1), STEMI with unknown symptom onset time (n=3), and cardiac arrest patients (n=2). Our hospital has offered 24/7 PPCI service to all eligible patients presenting with acute STEMI since 2010 per standard Accident and Emergency Department protocol. When STEMI is diagnosed, a PPCI team is activated after cardiology evaluation. Data on key time points in STEMI care are recorded in a clinical registry. Symptom-onset-to-first-medical-contact time is defined as the time from patient-reported chest discomfort onset time to the time of first medical contact. Door-to-device time is defined as the time from Accident and Emergency Department arrival to successful wire crossing time during PPCI. Catheterization laboratory arrival-to-device time is defined as the time from patient arrival in the catheterization laboratory to successful wire crossing time. From January 25, 2020, to February 10, 2020, we observed changes in time components of STEMI care among the aggregate group of 7 consecutive patients who underwent PPCI. We compared these with data from 108 patients with STEMI treated with PPCI in the prior year from February 1, 2018, to January 31, 2019 (N=108). These 7 patients did not suffer from COVID-19 infection, and 6 out of 7 presented to our hospital during regular work hours (8 am–8 pm weekdays, excluding public holidays). The Table shows numerically longer median times in all components when compared with historical data from the prior year. The largest time difference was in the time from symptom onset to first medical contact. Time Components of STEMI Care Before and After COVID-19 Outbreak The extent to which a community outbreak of infection like COVID-19 stresses other parts of healthcare system like STEMI care is largely unknown. Contemporary COVID-19 infection affects respiratory tract and is capable of human-to-human transmission presumably via droplets.[3,4] Given these concerns, Hong Kong hospitals implemented stringent infection control measures starting in late January 2020, including but not limited to universal masking, full personal protective equipment (N95 respirator, goggles/face shield, isolated gown, disposable gloves) for aerosol-generating procedures, frequent environmental disinfection, suspension of ward visit, volunteer service, and clinical attachment. Of course, these protocols are essential for limiting the spread of infections like COVID-19 but also may impact healthcare systems in unexpected ways. Most visibly, we found large delays in the small number of patients with STEMI seeking medical help after institution of these infection control measures. It is understandable that people are reluctant to go to a hospital during the COVID-19 outbreak, which explains the potential delays in seeking care. Another concern that we are unable to evaluate is whether some patients with STEMI did not seek care at all. Delays in seeking care or not seeking care could have a detrimental impact on outcomes. We also found delays in evaluating patients with STEMI after hospital arrival that could be explained by several reasons. For example, catheterization laboratories generally have positive pressure ventilation so COVID-19 infection inside these rooms can theoretically cause widespread contamination of the surrounding environment. Precautions such as detailed travel and contact history, symptomatology, and chest X-ray, therefore, are taken before transferring patients to the catheterization laboratory at our hospital. Although these are essential measures for containing COVID-19 infection, this could increase delays in diagnosis, staff activation and transfer if healthcare systems are not prepared. Similarly, even after patients arrived in the catheterization laboratory, staff may need more time to wear protective gear to prepare the patients and interventional cardiologists may not be used to performing PPCI while in full protective gear, leading to longer treatment. This is a preliminary report, and our study should be considered in the context of the following limitations. We describe a single hospital’s experience in STEMI care after instituting emergency infection protocols in a handful of patients. It is possible that patients and staff improve over time as their experiences with these measures mature. Although we cannot make meaningful statistical complications, our description allows for an early examination into how public health emergencies can indirectly affect unrelated hospital areas. In modern society, infectious agents like the COVID-19 outbreak can spread quickly and evolve into a pandemic. Hospitals not only need to consider methods for containing and treating these infections but how infection outbreaks may affect systems of care beyond the immediate infection.

Acknowledgment

We would like to thank all healthcare workers who have sacrificed themselves in the current coronavirus disease-19 (COVID-19) outbreak.

Disclosures

None.
Table.

Time Components of STEMI Care Before and After COVID-19 Outbreak

  4 in total

1.  2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Authors:  Patrick T O'Gara; Frederick G Kushner; Deborah D Ascheim; Donald E Casey; Mina K Chung; James A de Lemos; Steven M Ettinger; James C Fang; Francis M Fesmire; Barry A Franklin; Christopher B Granger; Harlan M Krumholz; Jane A Linderbaum; David A Morrow; L Kristin Newby; Joseph P Ornato; Narith Ou; Martha J Radford; Jacqueline E Tamis-Holland; Carl L Tommaso; Cynthia M Tracy; Y Joseph Woo; David X Zhao; Jeffrey L Anderson; Alice K Jacobs; Jonathan L Halperin; Nancy M Albert; Ralph G Brindis; Mark A Creager; David DeMets; Robert A Guyton; Judith S Hochman; Richard J Kovacs; Frederick G Kushner; E Magnus Ohman; William G Stevenson; Clyde W Yancy
Journal:  Circulation       Date:  2012-12-17       Impact factor: 29.690

2.  2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC).

Authors:  Borja Ibanez; Stefan James; Stefan Agewall; Manuel J Antunes; Chiara Bucciarelli-Ducci; Héctor Bueno; Alida L P Caforio; Filippo Crea; John A Goudevenos; Sigrun Halvorsen; Gerhard Hindricks; Adnan Kastrati; Mattie J Lenzen; Eva Prescott; Marco Roffi; Marco Valgimigli; Christoph Varenhorst; Pascal Vranckx; Petr Widimský
Journal:  Eur Heart J       Date:  2018-01-07       Impact factor: 29.983

3.  Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia.

Authors:  Qun Li; Xuhua Guan; Peng Wu; Xiaoye Wang; Lei Zhou; Yeqing Tong; Ruiqi Ren; Kathy S M Leung; Eric H Y Lau; Jessica Y Wong; Xuesen Xing; Nijuan Xiang; Yang Wu; Chao Li; Qi Chen; Dan Li; Tian Liu; Jing Zhao; Man Liu; Wenxiao Tu; Chuding Chen; Lianmei Jin; Rui Yang; Qi Wang; Suhua Zhou; Rui Wang; Hui Liu; Yinbo Luo; Yuan Liu; Ge Shao; Huan Li; Zhongfa Tao; Yang Yang; Zhiqiang Deng; Boxi Liu; Zhitao Ma; Yanping Zhang; Guoqing Shi; Tommy T Y Lam; Joseph T Wu; George F Gao; Benjamin J Cowling; Bo Yang; Gabriel M Leung; Zijian Feng
Journal:  N Engl J Med       Date:  2020-01-29       Impact factor: 176.079

4.  A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster.

Authors:  Jasper Fuk-Woo Chan; Shuofeng Yuan; Kin-Hang Kok; Kelvin Kai-Wang To; Hin Chu; Jin Yang; Fanfan Xing; Jieling Liu; Cyril Chik-Yan Yip; Rosana Wing-Shan Poon; Hoi-Wah Tsoi; Simon Kam-Fai Lo; Kwok-Hung Chan; Vincent Kwok-Man Poon; Wan-Mui Chan; Jonathan Daniel Ip; Jian-Piao Cai; Vincent Chi-Chung Cheng; Honglin Chen; Christopher Kim-Ming Hui; Kwok-Yung Yuen
Journal:  Lancet       Date:  2020-01-24       Impact factor: 79.321

  4 in total
  273 in total

1.  The fall in acute coronary syndrome admissions during the COVID-19 Portuguese lockdown.

Authors:  Daniel Candeias Faria; Miguel Borges Santos; Pedro Farto E Abreu
Journal:  Rev Port Cardiol       Date:  2021-01-02       Impact factor: 1.374

Review 2.  Preserving Access: A Review of Stroke Thrombectomy during the COVID-19 Pandemic.

Authors:  T M Leslie-Mazwi; K M Fargen; M Levitt; C P Derdeyn; S K Feske; A B Patel; J A Hirsch
Journal:  AJNR Am J Neuroradiol       Date:  2020-05-21       Impact factor: 3.825

3.  Effect of COVID-19 on hospital visits in Ningbo, China: an interrupted time-series analysis.

Authors:  Zong-Ming Yang; Meng-Yin Wu; Jie-Ming Lu; Tie-Zheng Li; Peng Shen; Meng-Ling Tang; Ming-Juan Jin; Hong-Bo Lin; Li-Ming Shui; Kun Chen; Jian-Bing Wang
Journal:  Int J Qual Health Care       Date:  2021-05-07       Impact factor: 2.038

4.  Myocardial infarction in the COVID-19 pandemic - Reperfusion therapy revisited.

Authors:  Jorge Ferreira
Journal:  Rev Port Cardiol       Date:  2021-06-05       Impact factor: 1.374

5.  Acute myocardial infarction in the Covid-19 era: Incidence, clinical characteristics and in-hospital outcomes-A multicenter registry.

Authors:  Alexander Fardman; Doron Zahger; Katia Orvin; Daniel Oren; Natalia Kofman; Jameel Mohsen; Or Tsafrir; Elad Asher; Ronen Rubinshtein; Jafari Jamal; Roi Efraim; Majdi Halabi; Yacov Shacham; Lior Henri Fortis; Tal Cohen; Robert Klempfner; Amit Segev; Roy Beigel; Shlomi Matetzky
Journal:  PLoS One       Date:  2021-06-18       Impact factor: 3.240

6.  COVID-19 and Cardiovascular Diseases.

Authors:  Babak Geraiely; Niloufar Samiei; Parham Sadeghipour; Azita H Talasaz; Seyedeh Hamideh Mortazavi; Roya Sattarzadeh Badkoubeh
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

7.  Impact of COVID-19 outbreak on patients with ST-segment elevation myocardial ınfarction (STEMI) in Turkey: results from TURSER study (TURKISH St-segment elevation myocardial ınfarction registry).

Authors:  Tuncay Kiris; Eyüp Avci; Tuba Ekin; Didar Elif Akgün; Mücahit Tiryaki; Arafat Yidirim; Kutluhan Hazir; Bektaş Murat; Mehtap Yeni; Rojhad Altindag; Sefa Gül; Baran Arik; Tuncay Güzel; Selda Murat; Ahmet Oz; Mustafa Karabacak; Zihni Aktas; Tarik Yildirim; Baris Kilicaslan; Asim Oktay Ergene
Journal:  J Thromb Thrombolysis       Date:  2021-05-29       Impact factor: 5.221

8.  Exploring the impact of the COVID-19 epidemic on the medical emergency calls and calls for cardiovascular diseases in Hangzhou, China.

Authors:  Juan Chen; Yong-Ran Cheng; Xin-Yan Fu; Chun-Yi Wang; Wen Wen; Jie Ni; Jing-Jie Jiang; Zhao Xu; Meng-Yun Zhou; Lan Ye; Zhan-Hui Feng; Gang Liu; Ming-Wei Wang; Xing-Wei Zhang; Zhong-Jun Ge; Guo-Fan Chen
Journal:  Ir J Med Sci       Date:  2021-05-21       Impact factor: 2.089

9.  Cardiovascular care in sub-Saharan Africa during the COVID-19 crisis: lessons from the global experience.

Authors:  Kishal Lukhna; Blanche Cupido; Jens Hitzeroth; Ashley Chin; Mpiko Ntsekhe
Journal:  Cardiovasc J Afr       Date:  2020 May/Jun       Impact factor: 1.167

10.  Missing Diagnoses during the COVID-19 Pandemic: A Year in Review.

Authors:  Héctor Pifarré I Arolas; Josep Vidal-Alaball; Joan Gil; Francesc López; Catia Nicodemo; Marc Saez
Journal:  Int J Environ Res Public Health       Date:  2021-05-17       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.